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Edited by Angel NebradaAbstract The G1/S phase restriction point is a critical check-
point that interfaces between the cell cycle regulatory machinery
and DNA replicator proteins. Here, we report a novel function
for the cyclin-dependent kinase inhibitor p27Kip1 in inhibiting
DNA replication through its interaction with MCM7, a DNA
replication protein that is essential for initiation of DNA replica-
tion and maintenance of genomic integrity. We ﬁnd that p27Kip1
binds the conserved minichromosome maintenance (MCM) do-
main of MCM7. The proteins interact endogenously in vivo in
a growth factor-dependent manner, such that the carboxyl termi-
nal domain of p27Kip1 inhibits DNA replication independent of
its function as a cyclin-dependent kinase inhibitor. This novel
function of p27Kip1 may prevent inappropriate initiation of
DNA replication prior to S phase.
Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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The cyclin-dependent kinase inhibitors (CKIs) are essential
regulators of cell proliferation that control transit through
the G1/S phase restriction point. The Cip/Kip CKIs p21Cip1,
p27Kip1, and p57Kip2 bind and inhibit cyclin-dependent kinases
(CDKs) required for cell cycle progression. p27Kip1 induces G1
arrest by inhibiting cyclin-CDK activity, predominantly cyclin
E-CDK2, thereby blocking events necessary for entry into S
phase and initiation of DNA replication. The CDK inhibitory
activity of p27Kip1 resides in a highly conserved domain (se-
quence identity 38–44%) that is present in the N-terminal of
all the Cip/Kip proteins. This 65 amino acid region is suﬃcient
to bind and inhibit cyclin-CDK complexes [1]. The carboxyl
terminals of the Cip/Kip proteins diﬀer in size and are more
divergent in sequence and function [2].Abbreviations: b-gal, b-galactosidase; BSA, bovine serum albumin;
CDK, cyclin-dependent kinase; CKI, cyclin-dependent kinase inhibi-
tor; CS, consensus sequence; DM, deletion mutants; FBS, fetal bovine
serum; MCM, minichromosome maintenance; NCBI, National Center
for Biotechnology Information; NLS, nuclear localization signal;
PAGE, polyacrylamide gel electrophoresis; WT, wild-type
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doi:10.1016/j.febslet.2005.10.028The carboxyl terminus of p27Kip1 is inactive as a CKI [3],
and its function is less clearly deﬁned. Recent studies indicate
that the carboxyl terminal of p27Kip1 contains a scatter domain
that is indispensable to p27Kip1 nuclear export and its role in
modulating cytoskeletal rearrangement and cell migration [3].
p27Kip1 protein stability is regulated through phosphorylation
of the carboxyl terminus at threonine 187 by CDK2, which
mediates its Skp2 dependent proteasomal degradation [4,5].
To investigate the functional importance of this domain, we
adopted a yeast two-hybrid screen to identify cDNAs encoding
proteins that speciﬁcally interact with the carboxyl terminal
moiety of p27Kip1. Among several clones isolated, we identiﬁed
MCM7, a replication initiator protein.
MCM7 belongs to a family of highly conserved proteins that
are essential to licensing DNA origins for initiation of DNA
replication. The minichromosome maintenance (MCM) pro-
teins were originally identiﬁed in yeast in a genetic screen iso-
lating mutants that are defective in maintaining
minichromosomes [6]. The MCM proteins, MCM2-7, are
highly conserved from yeast to humans and form a hexameric
complex in vivo that is recruited to DNA origins, where they
function as the replication fork helicase [7–10], melting DNA
origins in preparation for replication. Given that p27Kip1 is a
negative regulator of cell cycle progression, we hypothesized
that its interaction with MCM7 regulates the initiation of
DNA replication. We demonstrate that p27Kip1 and MCM7
interact in vitro and in mammalian cells in vivo and that the
carboxyl terminal of p27Kip1 inhibits DNA replication in a
CKI-dependent and independent manner.2. Materials and methods
2.1. Yeast two-hybrid screen
A yeast two-hybrid screen was performed using the Matchmaker
Two-Hybrid system (Clontech). The carboxyl terminal of p27Kip1 (aa
144–198) was fused to the GAL4 transcriptional activator
(pGBT9p27Kip1) and employed as bait in a screen of a human B-cell
library [11] fused to the GAL4 activating domain. Interactions were
tested by cotransfection of GAL4 DNA-binding domain-fused genes
and clones [amino terminus p27Kip1, full-length p27Kip1, p57Kip2 sub-
cloned into pGBT9 [12]; pGBT9 backbone, pLAM50 (human lamin
C/GAL4 DNA binding domain), and pVA3 (murine p53/GAL4 bind-
ing domain) negative controls] into Saccharomyces cerevisiae. b-galac-
tosidase (b-gal) assays were used to determine interactions with
MCM7. National Center for Biotechnology Information (NCBI) on-
line service was used to identify clone sequence and make sequence
comparisons.f European Biochemical Societies.
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Crude cell lysates of GST-fusion proteins were prepared and puriﬁed
per manufacturers instructions (Amersham). GST-fusion protein
amounts were determined by comparing with a bovine serum albumin
(BSA) standard on SDS–polyacrylamide gel electrophoresis (PAGE)
after Comassie staining. [35S]-methionine-labeled proteins were pro-
duced using a TNT T7-coupled reticulolysate system (Promega). Bind-
ing assays were performed by incubating 10 ll of [35S]-methionine-
labeled proteins with equal molar amounts of GST-fusion proteins
bound to glutathione sepharose 4B beads in EBC buﬀer (50 mM Tris,
pH 8.0, 120 mM NaCl, 1% NP-40, 2 mM NaF, 200 lM sodium ortho-
vanadate, a protease inhibitor cocktail [Complete, Roche]) for
60 min at 4 C. Following incubation, beads were washed four times
with EBC buﬀer, and bead-bound proteins were eluted by boiling
the beads in 10 ll of SDS gel loading buﬀer and analyzed by SDS–
PAGE.
2.3. Immunoprecipitation and Western blot
Antibodies used for immunoprecipitation and Western blot in-
cluded: p27Kip1 M197 rabbit anti-human polyclonal antibody (Santa
Cruz); p27Kip1 mouse anti-human monoclonal antibody (Transduction
Laboratories); MCM7 715 anti-human polyclonal antibody raised in a
rabbit immunized with 487ANPAYGRYNPRRSLEQNIQL506, a
MCM7-speciﬁc peptide; and MCM7 mouse anti-human monoclonal
antibody (Santa Cruz). MCM7 715 antibody was aﬃnity puriﬁed with
an AminoLink plus Immobilization kit (Pierce) using GST-MCM7 as
an antigen. Western blots and immunoprecipitations were performed
as described [13]. In brief, cell lysis and immunoprecipitations used
1% NP-40 lysis buﬀer containing a protease inhibitor cocktail and
phosphatase inhibitors (200 lM sodium orthovanadate, 2 mM NaF),
and 2 lg antibody per 500 lg lysate. Immunoprecipitated proteins
were loaded on a 4–15% gel and analyzed by Western blot.
2.4. Cell culture
NIH 3T3 cells, 293 cells, and mouse ﬁbroblasts were maintained in
Dulbeccos modiﬁed Eagles medium (GibcoBRL) containing 10% fe-
tal bovine serum (FBS), 2 mM glutamine and penicillin/streptomycin.
NIH 3T3 cells were treated with 2 lg/ml leptomycin B, and 50 lM lact-
acystin, to block export of nuclear proteins and protein degradation,
respectively [12].
2.5. Construction of MCM7 deletion mutants and truncated
p27Kip1(81-198)
MCM7 deletion mutant (DM) constructs were generated by
PCR using the following primers. DM-1(aa1-332): 5
0 Primer A
(TCAGAATTCGCAGCGATGGCACTGAAGGAC) and 30 Primer A
(AAAGCGGCCGCTCAATCCTCCTCTGCAATTTG); DM-2(aa1-538):
5 0 Primer A and 3 0 Primer B (AAAGCGGCCGCTCACATGTCCA-
GAGGTTCAAA); DM-3(aa332-538): 5
0 Primer B (TCAGAATTCTTC-
TACGAAAAGCTGGCA) and 3 0 Primer B; DM-4(aa538-719): 5 0
Primer C (TCGGAATTCTATGTGCACCAGCACAGC) and 3 0 Pri-
mer C (AAAGCGGCCGCTCAGACAAAAGTGATCCG); and
DM-5(aa332-719) contained DM-3 (5
0 Primer B) and DM-4 (3 0 Primer
C). The constructs were cloned into the pCDNA3.1 vector, and the
DM proteins were produced using a TNT T7-coupled reticulolysate
system (Promega). The truncated p27Kip1(81-198) construct, which
lacks the CDK inhibitory domain, was generated by PCR
(5 0tp27primer-AAGGGATCCTACAGACCCCCGCGGCCC and
3 0tp27primer-AAGGGATCCTTAGCGGAGCAATGCGCAGGAA-
TAAGG). The construct was cloned into pGEX-6P, and the GST-fu-
sion protein was generated.
2.6. In vitro DNA replication assay
Xenopus eggs extracts were prepared as previously described [14].
DNA replication was measured by supplementing Xenopus egg ex-
tracts with 0.3 mM CaCl2 for 10 min at room temperature. The ex-
tracts were incubated in the presence of 250 lg/ml cyclohexamide,
24 mM phosphocreatine, 30 lg/ml creatine phosphokinase, and
10 lM ﬂuorescein-dUTP with chromatin and recombinant p21Cip1,
full-length p27Kip1, or truncated p27Kip1(81-198) at 22 C for 90 min.
The nuclei were ﬁxed in 100 ll 4% formaldehyde, spun onto a slide
using a cytospin, and mounted in a DAPI containing medium (Vector
Labs). The fraction of labeled nuclei was counted by ﬂuorescence
microscopy [15].Wild-type (WT) and p27/ ﬁbroblasts were used to generate chro-
matin templates. Serum-starved WT and p27/ ﬁbroblasts were tryp-
sinized and washed twice in Transport buﬀer (20 mM HEPES (pH
7.3), 110 mM potassium acetate, 5 mM sodium acetate, 2 mM magne-
sium acetate, 1 mM EGTA, 2 mM DTT, 1 lg/ml aprotinin, 1 lg/ml
pepstatin, 1 lg/ml leupeptin). Cells were resuspended in Transport buf-
fer at a concentration of 1 · 106 cells/ml and incubated with an equal
volume of digitonin (80 lg/ml) at 4 C for 5 min. Cells were then incu-
bated with an equal volume of 3% BSA and centrifuged at 200 · g at
4 C for 10 min. Cells were then washed in ice-cold Transport buﬀer
three times and resuspended in 10% glycerol/Transport buﬀer at a con-
centration of 3 · 106 cells/ml and stored at 80 C before use in DNA
replication assay. Recombinant full-length p27Kip1, p21Cip1 and trun-
cated p27Kip1(81-198) were used. The serum-starved nuclei were in
G0 phase of the cell cycle.
To conduct the time course experiments, recombinant full-length
p27Kip1 and truncated p27Kip1(81-198) were added to the chromatin
templates, and DNA replication was measured 60 or 120 min later.
Equivalent volumes were used in the BSA control, full-length
p27Kip1 and truncated p27Kip1(81-198) conditions.
2.7. Kinase assay
An H1 kinase assay was performed as previously described [16]. Egg
extracts were released with 0.3 mM CaCl2 in the presence of chroma-
tin, recombinant full-length p27Kip1 and truncated p27Kip1(81-198),
were incubated at room temperature for 30, 60, 90 and 120 min, and
then were used in the kinase assay. 10 ll of extract was diluted 1:10
in an immunoprecipitation buﬀer, consisting of 100 mM NaCl,
50 mM, a-glycerophosphate, 5 mM EDTA, 0.1% Triton X-100,
1 mM DTT and a protease inhibitor cocktail [Complete], to which
2 ll cyclin E crude antisera (generous gift of P. Jackson) or IgG control
was added. Immunoprecipitates were subjected to a histone H1 kinase
assay at 25 C for 15 min, quenched in sample buﬀer, resolved by
SDS–PAGE and analyzed by autoradiography.
2.8. Statistical analysis
Experimental data were analyzed by ANOVA followed by Bonfer-
roni correction. Results are expressed as mean ± S.E.M. Statistical sig-
niﬁcance is considered at the P 6 0.05 level.3. Results
3.1. Identiﬁcation of MCM7 as a carboxyl terminal p27Kip1-
interacting protein
To characterize the function of the carboxyl terminal of
p27Kip1, we employed a yeast two-hybrid approach to
screen a human B cell library using the carboxyl terminal do-
main of p27Kip1 fused to the DNA-binding domain of the
GAL4 transcription activator as bait. This carboxyl terminal
region, in contrast to the amino terminal domain, does not
bind cyclin/CDKs and is inactive as a CKI. We isolated a
2.6 kb cDNA encoding MCM7, a 719 aa protein that migrates
at approximately 83–85 kDa. As shown in Fig. 1, MCM7
interacts with full-length p27Kip1, the carboxyl terminal of
p27Kip1, and p57Kip2, a Cip/Kip CKI whose carboxyl
domain is similar to p27Kip1. However, MCM7 does not
bind the amino terminal of p27Kip1 or three negative con-
trols, pGBT9 backbone, pLAM5 0, and pVA3 (data not
shown).3.2. MCM7 interacts with p27Kip1 in vitro
A speciﬁc physical interaction between MCM7 and p27Kip1
was noted in yeast cells, and we investigated further the nature
and speciﬁcity of the association. To determine whether
MCM7 directly binds p27Kip1, 35S-labeled, in vitro translated
MCM7 was incubated with GST-p27Kip1 fusion protein bound
Fig. 1. MCM7 interacts with full-length p27Kip1, the carboxyl terminal of p27Kip1, and p57Kip2, but not the amino terminal of p27Kip1 in S. cerevisiae.
MCM7 was cotransfected with p27Kip1, p27Kip1(1-88), p27Kip1(144-198), or p57Kip2, and three negative controls (pGBT9 backbone, pLAM50, pVA3)
into yeast. b-gal assays were performed on selection plates with cotransfected yeast, and the presence (+) or absence () of staining was noted. No
staining was observed with the three negative controls.
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recovered by SDS–PAGE. Consistent with the yeast two-hy-
brid data, in vitro translated MCM7 bound GST-p27Kip1
(Fig. 2A, lane 3). To further investigate the speciﬁcity of the
interaction between MCM7 and p27Kip1, we studied MCM7
binding to CKIs. In vitro translated MCM7 was incubated
with the Cip/Kip CKIs GST-p57Kip2 and GST-p21Cip1, and
INK4 CKI GST-p16Ink4. Equal moles of each fusion protein
were used (Fig. 2B). MCM7 bound p57Kip2, weakly interacted
with p21Cip1 and did not interact with p16Ink4 (Fig. 2A, lanes 6,
9, and 12, respectively). This interaction suggests that the spec-
iﬁcity of MCM7-CKI interaction is limited to the Cip/Kip
CKIs, which are structurally and functionally distinct from
the INK4 CKI proteins. A stronger association was observed
between MCM7 and Kip CKIs p27Kip1, p57Kip2 compared to
MCM7-p21Cip1. This pattern underscores the importance of
the shared motifs in the carboxyl terminals of p27Kip1 and
p57Kip2 to the MCM7 interaction.Fig. 2. (A) MCM7 binds the Cip/Kip CKIs p27Kip1, p57Kip2, p21Cip1 in vi
p57Kip2, p21Cip1, and p16Ink4a were bound to glutathione sepharose beads and
labeled MCM7 was analyzed by SDS–PAGE and autoradiography. Input is
Equal moles of each fusion protein were used determined by Coomassie sta3.3. The MCM domain is essential to the MCM7 and p27Kip1
interaction
To determine the MCM7 region that binds p27Kip1, we gen-
erated DMs (Fig. 3A and B). MCM family members display
sequence conservation in a central 200 amino acid region
containing an ATPase element similar to the A motif of Walker-
type NTP-binding sequence found in ATPases. DMs were con-
structed to include the amino terminal of MCM7 only (DM-1),
the amino terminal and the MCM domain (DM-2), the con-
served MCM domain only (DM-3), the carboxyl terminal only
(DM-4), and the combined conserved MCM domain and the
carboxyl terminal (DM-5). In vitro translated WT MCM7
and DMs were incubated with equal moles of GST-p27Kip1
or GST, and co-precipitates were analyzed by SDS–PAGE.
p27Kip1 bound DM-2 and DM-3, suggesting that the conserved
MCM domain is essential to the interaction between MCM7
and p27Kip1 (Fig. 3C, lanes 6 and 8). Weak binding of DM-4
to p27Kip1 was observed, suggesting that the carboxyl terminaltro but not the INK4 CKI p16Ink4a. GST-fusion proteins of p27Kip1,
incubated with 35S-labeled in vitro translated MCM7. Co-precipitated
1:10 dilution of 1/10 of [35S]-methionine labeled MCM7 product. (B)
ining.
Fig. 3. p27Kip1 binds the conserved MCM domain in MCM7 and p27Kip1. (A) Schematic representation of MCM7 DMs. (B) SDS–PAGE and
autoradiography of [35S]-methionine labeled WT MCM7 and DMs. (C) p27Kip1 binds DM-2, DM-3, DM-5 avidly, and DM-4 weakly, suggesting
that the conserved MCM domain is important in the p27Kip1–MCM7 interaction. GST-p27Kip1 proteins, in equal molar amounts, were bound to
glutathione sepharose beads and incubated with 35S-labeled, in vitro translated WT MCM7, DM-1, 2, 3, 4, and 5. Co-precipitated labeled proteins
were analyzed by SDS–PAGE. (D) Quantiﬁcation of p27Kip1 binding to MCM7 DMs as shown in C.
6532 S. Nallamshetty et al. / FEBS Letters 579 (2005) 6529–6536of MCM7 may also be involved in the interaction (Fig. 3C,
lane 10). The interaction between DM-5 and p27Kip1 was
stronger than binding to DM-3 or DM-4 alone (Fig. 3C, lane
12 and D). However, DM1, which is missing both the MCM
domain and C-terminus did not bind to p27Kip1 (Fig. 3C, lane
4). Taken together, these data suggest that the conserved
MCM domain is critical to binding, while the carboxyl termi-
nal plays a more minor role.
3.4. MCM7 associates with p27Kip1 in mammalian cells
To analyze MCM7–p27Kip1 interactions in vivo, we ﬁrst
raised an anti-human MCM7 polyclonal antibody in a rabbit
(MCM7 715). The speciﬁcity of MCM7 715 was tested by Wes-
tern blot and absorption tests using GST-fusion proteins
(Fig. 4). MCM7 715 antibody was incubated with unabsorbed
antibody (Co), GST-MCM7 inclusion bodies, or an unrelated
fusion protein GST-C19, and applied in a Western blot with
293 cell lysates. An 85-kDa band was not detected when
MCM7 715 was absorbed with GST-MCM7 inclusion bodies
(Fig. 4A, lane 2), compared to controls (Fig. 4A, lanes 1 and
3), demonstrating speciﬁcity of the antibody for MCM7.
To determine whether MCM7 and p27Kip1 associate in vivo,
we studied NIH 3T3 cells that were synchronized by serum
starvation for 36 h, and then released by addition of 20%
FBS and treated with 50 lM lactacystin (protein degradation
inhibitor) and 2 lg/ml leptomycin B (nuclear export inhibitor)
for 8 h. Cell lysates were immunoprecipitated with MCM7 715
antibody and analyzed by Western blot using a monoclonalanti-human p27Kip1 antibody. p27Kip1 coimmunoprecipitated
with MCM7 in synchronized cycling NIH 3T3 cells (Fig. 4B,
lane 3), but not in the serum starved cells (Fig. 4B, lane 2).
MCM7–p27Kip1 interaction was not observed with a control
IgG antibody (Co) (Fig. 4B, lane 1). Western blot of p27Kip1
protein in serum starved and serum stimulated lactacystin trea-
ted cell lysates showed no change in p27Kip1 levels (Fig. 4B,
lanes 4 and 5).
An additional immunoprecipitation was also performed
where cell lysates were immunoprecipitated with a monoclo-
nal anti-human p27Kip1 antibody and analyzed by Western
blot with the MCM7 715 antibody. MCM7 coimmunoprecip-
itated with p27Kip1 in cycling cells (Fig. 4C, lane 3), but not in
serum starved cells (Fig. 4C, lane 2). The p27Kip1–MCM7
interaction was not immunoprecipitated with a control IgG
antibody (Fig. 4C, lane 1), and a Western blot of MCM7 pro-
tein in serum starved and serum stimulated cell lysates dem-
onstrated no change in MCM7 protein levels (Fig. 4C,
lanes 4 and 5). MCM7 715 antibody eﬃciently pulled down
MCM7 protein as shown in Fig. 4D. Taken together, these
data suggest that p27Kip1 and MCM7 asso- ciate in mamma-
lian cells in a growth factor dependent manner.3.5. The p27Kip1 carboxyl terminal is inactive as a CKI, but it
does inhibit DNA replication
Given that p27Kip1–MCM7 interact in yeast, in vitro, and in
mammalian cells in vivo, we investigated the functional impor-
Fig. 4. MCM7 associates with p27Kip1 in mammalian cells. (A) Speciﬁcity of anti-human MCM7 antibody for MCM7 (lane 2) compared with
controls (lanes 1 and 3). (B) Endogenous interaction of MCM7 and p27Kip1 in mammalian cells. Cell lysates harvested from serum starved 3T3 cells
were released with 20% FBS, treated with leptomycin B and lactacystin, subjected to immunoprecipitation with anti-human MCM7 715 or control
IgG antibody, and analyzed by Western blot with an anti-human p27Kip1 antibody. (C) Endogenous interaction of p27Kip1 and MCM7 in
mammalian cells. Cell lysates were treated as above and subjected to immunoprecipitation with anti-human p27Kip1 antibody or control IgG
antibody and analyzed by Western blot with an anti-human MCM7 715 antibody. (D) A MCM7 immunoprecipitation is shown which includes the
fraction of immunoprecipitated MCM7 relative to the 10% input.
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p27Kip1 inhibits DNA replication given its well described func-
tion as a negative regulator of cell cycle progression. To inves-
tigate this hypothesis, we utilized a cell free in vitro replication
assay. Chromatin templates from skin ﬁbroblasts of p27+/+
(WT) and p27/ (null) mice were generated in order to inves-
tigate the role of endogenous p27Kip1 on DNA replication. We
observed a signiﬁcant reduction in the percentage of nuclei
undergoing DNA replication in chromatin templates prepared
from p27+/+ cells compared to p27/ cells (Fig. 5A, lane 2 vs.
1) (P < 0.05), suggesting that p27Kip1 directly inhibits DNA
replication.
Since inhibition of cyclin E/CDK2 arrests DNA replication
in this assay [16], we examined whether p27Kip1 inhibits DNA
replication solely in a CKI dependent manner or by a CKI inde-
pendent mechanism as well. To test this hypothesis, we gener-
ated a truncated p27Kip1 mutant, consisting of the carboxyl
portion of p27Kip1 but lacking the CKI domain (aa 81-198).
We investigated whether the addition of exogenous full length
or truncated p27Kip1 protein as well as full-length p21Cip1 (as
a control) to the Xenopus egg extracts would inhibit DNA rep-
lication. Chromatin templates were prepared from p27/ cells
to avoid endogenous p27Kip1 activity. Addition of p21Cip1 to
the DNA replication reaction resulted in a signiﬁcant inhibition
of DNA replication compared to p27/ cells (Fig. 5A, lane 3
vs. 2) (P 6 0.001); this p21Cip1 eﬀect is likely mediated by cyclin
E inhibition [7,16]. Addition of recombinant full-length p27Kip1
to the chromatin templates signiﬁcantly inhibited DNA replica-
tion in a dose dependent manner (Fig. 5A, lanes 4, 5, 6 vs. 2; 5B
upper panel) (P 6 0.01, 20 nM; P < 0.001, 200 and 400 nM,
respectively). Addition of recombinant truncated p27Kip1
[p27(81-198)] protein also signiﬁcantly inhibited DNA replica-
tion (Fig. 5A, lanes 7, 8, 9 vs. 2; 5B upper panel) (P 6 0.05,
20 nM; P < 0.001, 200 and 400 nM), although the extent of
the eﬀect was not as great as full-length p27Kip1 at the 200
and 400 nM doses.To further investigate the possible CKI independent role of
p27Kip1, we performed a time course experiment, examining
the percent of replicating cells at 60 min (CKI independent
function) and 120 min (CKI dependent function) following
addition of recombinant full-length p27Kip1 or truncated
p27Kip1 to the chromatin templates. We hypothesized that dur-
ing the ﬁrst 60 min most of the nuclei are in early G1 phase
with low CDK activity (Fig. 5F). Therefore, at this stage the
inhibition of DNA replication by p27Kip1 would be indepen-
dent of its CKI activity. Furthermore, the degree of inhibition
should be similar between p27Kip1 full length and truncated
p27Kip1 at 60 min. At the later time point (120 min), CDK2
activity is maximum, and p27Kip1 inhibitory eﬀects should re-
ﬂect its CKI function. We found that full-length p27Kip1 and
truncated p27Kip1 equally inhibited DNA replication at
60 min before G1 arrest occurs (80% and 66%, respectively,
both P 6 0.01 compared with control) (Fig. 5C, lanes 2 and 3
vs. 1, and 5D). However, full-length p27Kip1 achieved a greater
inhibition at 120 min compared with truncated p27Kip1 (86%
and 51%, P 6 0.001 and P 6 0.01, respectively, compared
with control) (Fig. 5C, lanes 5 and 6 vs. 4, and 5E), suggesting
that p27Kip1 indeed does inhibit DNA replication independent
of its CKI function.
In addition, we explored the ability of full-length p27Kip1
and truncated p27Kip1 to inhibit cyclin E activity using an
H1 kinase assay. We found that full-length p27Kip1 completely
inhibited cyclin E activity, while truncated p27Kip1 failed to in-
hibit cyclin E activity (Fig. 5F). These data further support the
hypothesis that p27Kip1 inhibits DNA replication independent
of its CKI function.4. Discussion
p27Kip1 was ﬁrst described as a negative regulator of G1 pro-
gression through its eﬀects on mediating cell contact and
Fig. 5. The carboxyl terminal of p27Kip1 inhibits DNA replication. (A) Quantiﬁcation of DNA replication. Chromatin templates for DNA
replication were obtained from nuclei of WT p27Kip1 (p27+/+) (lane 1) and p27/ ﬁbroblasts (lanes 2–9) and treated with recombinant p21Cip1 (lane
3), WT p27Kip1 (lanes 4–6), and carboxyl terminal p27Kip1 [p27(81-198)] (lanes 7–9). The fraction of replicating nuclei was quantiﬁed by ﬂuorescent
microscopy. Recombinant protein concentrations are in nM. All assays were performed in triplicate, n = 3. *P 6 0.05, **P 6 0.01, ***P < 0.001. (B)
Fluorescent microscopy of DNA replication assays from (A). Fluorescein-dUTP treated Xenopus egg extracts and chromatin templates isolated from
p27/ ﬁbroblasts (left), WT p27Kip1 (middle) and truncated p27Kip1 containing the carboxyl terminal [p27(81-198)] (right) are shown in the upper
panel; DAPI labeled nuclei are in the lower panel. (C) Time course assay of DNA replication. Chromatin templates for DNA replication were
obtained from p27/ ﬁbroblasts and treated with recombinant full-length p27Kip1 (lanes 2 and 5), or truncated p27Kip1[p27(81-198)] (lanes 3 and 6),
and DNA replication was measured 60 min (lanes 1–3) or 120 min (lanes 4–6) later. All assays were performed in triplicate, n = 3. **P 6 0.01,
***P < 0.001. Co is BSA control. Equal volumes were used to prevent a dilution eﬀect from the addition of 200 nM protein. (D, E) Fluorescent
microscopy of DNA replication assays from (C). Fluorescein-dUTP treated Xenopus egg extracts and chromatin templates isolated from p27/
ﬁbroblasts that were treated with control buﬀer (BSA, left), recombinant WT p27Kip1 protein (middle), or truncated p27Kip1 [p27(81-198)] protein
(right) are shown at 60 min (D) and 120 min (E) (upper panels). DAPI labeled nuclei are shown in the lower panels of D and E. (F) Cyclin E/CDK2
kinase assay. Replication extracts were mixed with BSA (Co) (upper panel), truncated p27Kip1 [p27(81-198)] (middle panel) and full-length p27Kip1
(bottom panel), incubated at 22 C for the indicated amount of time and immunoprecipitated with antisera speciﬁc for Xenopus cyclin E or control
IgG (Co). Immune complex kinase assays for H1 kinase activity were performed, assessed by SDS–PAGE, and followed by autoradiography.
6534 S. Nallamshetty et al. / FEBS Letters 579 (2005) 6529–6536TGFb-induced G1 arrest [17,18]. However, subsequent studies
have demonstrated that p27Kip1 and other Cip/Kip proteins
function in additional pathways involving DNA replication,
cyclin/CDK assembly, apoptosis, cell migration and cytoskele-
tal reorganization [19]. In the present study, we identify
MCM7 as a p27Kip1 carboxyl terminal interacting protein
and demonstrate that p27Kip1 negatively regulates DNA repli-
cation. We ﬁnd that full-length p27Kip1 is a potent inhibitor of
DNA replication in a cell-free Xenopus based in vitro assay.
Given that early events in DNA replication require cyclin E/
CDK2 activity [16], we reason that this inhibitory function
of full-length p27Kip1 is attributable to the conserved amino
terminal CDK inhibitory domain. Given the evidence support-
ing an expanding role for p27Kip1 in cell cycle regulatory path-ways not directly related to CDK inhibition, as well as the
observed speciﬁc interaction of the carboxyl terminal of
p27Kip1 with MCM7, we hypothesized that p27Kip1 inhibits
DNA replication in both a CKI dependent and CKI indepen-
dent fashion. We now report that truncated p27Kip1 lacking the
CDK inhibitory domain inhibits DNA replication in this sys-
tem, suggesting a novel regulatory function of the carboxyl ter-
minus of p27Kip1 in control of initiation of DNA replication.
A growing body of evidence implicates proteins that govern
the G1/S restriction point such as CDKs/CKIs and Rb in the
regulation of DNA replication. For instance, p21Cip1 has a
dual function as a cell cycle inhibitor. In addition to regulating
CDK activity, p21Cip1 also binds to proliferating cell nuclear
antigen (PCNA) and inhibits in vitro PCNA dependent
S. Nallamshetty et al. / FEBS Letters 579 (2005) 6529–6536 6535DNA replication [20]. The Rb gene product interacts with
MCM7 and inhibits DNA replication in a MCM7-dependent
manner [21]. In addition, the E2F-Rb complex controls
DNA replication by interacting with the origin recognition
complex in Drosophila [22]. The interaction of p27Kip1 with
MCM7 may regulate the precise timing of DNA replication
and may represent a mechanism that prevents premature ﬁring
at origins in late G1.
According to a replication-licensing model, replication ori-
gins oscillate between two chromatin states: a pre-replication
and a post-replication state [23]. In order to maintain the integ-
rity of the genome, eukaryotic cells must prevent premature ﬁr-
ing of origins in G1 and reduplication in S-M phases. During
the pre-replication state (G1), a set of replication initiator
factors sequentially assemble into pre-replicative complexes
(Pre-RC) at origins [24], thereby rendering the chromatin com-
petent for replication. The origin recognition complex (ORC)
serves as a scaﬀold for recruitment of Cdc6 and Cdt1, which
cooperatively facilitate loading of the MCM hexamer [25–
27]. Phosphorylation of the MCM hexamer by the Dbf4-
cdc7 kinase (DDK) and cyclin E/CDK activity in early S phase
leads to a conformational change in the MCM complex and
the recruitment of Cdc45 and subsequently RPA, a primase,
and DNA polymerase [28–30]. Recent studies demonstrate
that the Xenopus homologues of p27Kip1 (Xic1) and MCM pro-
teins are present at origins prior to the G1/S transition [31].
Previous work suggests that CDK activity may directly regu-
late DNA replication [16]. Additionally, one of the main sub-
strates of CDKs, Rb, directly regulates DNA replication by
binding to MCM7 [21]. Furthermore, a recent study suggests
that CDK activity leads to the dissociation of Rb:MCM7
[32]. Since p27Kip1 binds to and inhibits CDK complexes, it
is interesting to speculate that the p27Kip1 CKI dependent inhi-
bition of DNA replication we observed might involve such a
mechanism. Given that p27Kip1 also inhibits DNA replication
in a CKI independent manner, it is possible that the p27Kip1–
MCM7 interaction represents a regulatory mechanism that re-
strains inappropriate initiation of DNA replication prior to S
phase.
Alternatively, the p27Kip1–MCM7 interaction may be neces-
sary for the recruitment of p27Kip1 to origins. In Xenopus, Xic1
is recruited to origins along with cyclin E/CDK, and this
recruitment is necessary for its degradation and progression
to G1/S phase transition [31]. The recruitment of cyclin E,
which is necessary for Xic1 localization to origins, occurs in
a Cdc6-dependent fashion [33], suggesting that DNA replica-
tion machinery may play an important role in this process.
In addition, studies in Xenopus extracts demonstrate that
immunodepletion of MCM7 from these extracts blocks the
recruitment of Xic1 to origins as well as Xic1 degradation, pro-
viding indirect evidence for the importance of MCM7 and rep-
lication machinery in the Xic1 degradation [34]. A similar
process may exist in mammalian cells.
In summary, we report a novel function for the CKI p27Kip1
in inhibiting DNA replication through its interaction with
MCM7. p27Kip1 binds the MCM domain of MCM7, and the
proteins interact endogenously in vivo in a growth factor-
dependent manner, such that the carboxyl terminal domain
of p27Kip1 inhibits DNA replication in a CKI dependent and
CKI independent manner. This novel function of p27Kip1
may prevent inappropriate initiation of DNA replication prior
to S phase.Acknowledgments: We thank members of the Nabel Lab for helpful
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